Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost–Consequence Analysis for High-Risk Patients in Primary Care in Germany
Using Xpert Xpress at POC combined fast turnaround with high diagnostic accuracy, thereby increasing correct treatment courses while reducing total costs for influenza, COVID-19, and RSV, offering substantial savings to the German SHI.
Authors
- Tray Brown (ORCID: https://orcid.org/0000-0002-2632-8640)
- Johannes Pöhlmann (ORCID: https://orcid.org/0000-0002-8065-755X)
- Anika Joecker
- Jordan Hinahara (ORCID: https://orcid.org/0000-0002-2610-5340)
- Richard Fulton Pollock (ORCID: https://orcid.org/0000-0002-9873-7507)
- Tanja Wittki
Institutions
- A-T Society (GB)
- Covalence Research
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1007/s12325-025-03156-0
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Cepheid